AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
- Posted on October 17, 2024
- By Bing News
- 2 Views
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.
